Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome

Livia Guadagnoli, Ece A. Mutlu, Bethany Doerfler, Ammoura Ibrahim, Darren Brenner, Tiffany H. Taft*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Background: Food-related quality of life (FRQoL) evaluates the impact of diet, eating behaviors, and food-related anxiety on a person’s quality of life. This is the first study to evaluate FRQoL in inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), two illnesses where food and diet are of importance. Methods: One hundred seventy-five participants (80 IBS, 95 IBD) participated in the study by completing measures evaluating FRQoL, psychological distress, and health-related quality of life. Primary analyses evaluated differences in FRQoL between IBD and IBS patients. Secondary analyses compared differences based on remission status, dietary use, and dietary consultation, as well as evaluated potential predictors of FRQoL. Results: IBD patients in remission report the highest FRQoL (IBD-remission: 91.2 (26.5) vs. IBD-active: 67.7 (19.6) and IBS-active: 67.6 (18.3), p <.001). Using more dietary treatments is associated with decreased FRQoL for IBS (r = − 0.23, p <.05) and IBD patients (r = − 0.31, p <.01). IBS patients are more likely to use dietary treatments than IBD (IBS = 81% vs. IBD = 64%, p <.01), with self-directed diets being the most commonly used approach. Symptom severity is the strongest predictor of FRQoL in both groups (IBD: R2 =.27, p <.01; IBS: R2 =.23, p <.001). Conclusion: FRQoL is a unique construct for IBD and IBS patients that can be influenced by several clinical and dietary factors, including number of diets and type of diet used, depending on the diagnosis. Thus, FRQoL should be considered when working with both IBD and IBS patients.

Original languageEnglish (US)
Pages (from-to)2195-2205
Number of pages11
JournalQuality of Life Research
Volume28
Issue number8
DOIs
StatePublished - Aug 15 2019

Fingerprint

Food Quality
Irritable Bowel Syndrome
Inflammatory Bowel Diseases
Quality of Life
Diet
Food
Feeding Behavior
Referral and Consultation
Anxiety

Keywords

  • Diet
  • Inflammatory bowel disease
  • Irritable bowel syndrome
  • Outcomes research
  • Quality of life

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Guadagnoli, Livia ; Mutlu, Ece A. ; Doerfler, Bethany ; Ibrahim, Ammoura ; Brenner, Darren ; Taft, Tiffany H. / Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome. In: Quality of Life Research. 2019 ; Vol. 28, No. 8. pp. 2195-2205.
@article{76fe66587ed64b419754c498c486b656,
title = "Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome",
abstract = "Background: Food-related quality of life (FRQoL) evaluates the impact of diet, eating behaviors, and food-related anxiety on a person’s quality of life. This is the first study to evaluate FRQoL in inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), two illnesses where food and diet are of importance. Methods: One hundred seventy-five participants (80 IBS, 95 IBD) participated in the study by completing measures evaluating FRQoL, psychological distress, and health-related quality of life. Primary analyses evaluated differences in FRQoL between IBD and IBS patients. Secondary analyses compared differences based on remission status, dietary use, and dietary consultation, as well as evaluated potential predictors of FRQoL. Results: IBD patients in remission report the highest FRQoL (IBD-remission: 91.2 (26.5) vs. IBD-active: 67.7 (19.6) and IBS-active: 67.6 (18.3), p <.001). Using more dietary treatments is associated with decreased FRQoL for IBS (r = − 0.23, p <.05) and IBD patients (r = − 0.31, p <.01). IBS patients are more likely to use dietary treatments than IBD (IBS = 81{\%} vs. IBD = 64{\%}, p <.01), with self-directed diets being the most commonly used approach. Symptom severity is the strongest predictor of FRQoL in both groups (IBD: R2 =.27, p <.01; IBS: R2 =.23, p <.001). Conclusion: FRQoL is a unique construct for IBD and IBS patients that can be influenced by several clinical and dietary factors, including number of diets and type of diet used, depending on the diagnosis. Thus, FRQoL should be considered when working with both IBD and IBS patients.",
keywords = "Diet, Inflammatory bowel disease, Irritable bowel syndrome, Outcomes research, Quality of life",
author = "Livia Guadagnoli and Mutlu, {Ece A.} and Bethany Doerfler and Ammoura Ibrahim and Darren Brenner and Taft, {Tiffany H.}",
year = "2019",
month = "8",
day = "15",
doi = "10.1007/s11136-019-02170-4",
language = "English (US)",
volume = "28",
pages = "2195--2205",
journal = "Quality of Life Research",
issn = "0962-9343",
publisher = "Springer Netherlands",
number = "8",

}

Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome. / Guadagnoli, Livia; Mutlu, Ece A.; Doerfler, Bethany; Ibrahim, Ammoura; Brenner, Darren; Taft, Tiffany H.

In: Quality of Life Research, Vol. 28, No. 8, 15.08.2019, p. 2195-2205.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome

AU - Guadagnoli, Livia

AU - Mutlu, Ece A.

AU - Doerfler, Bethany

AU - Ibrahim, Ammoura

AU - Brenner, Darren

AU - Taft, Tiffany H.

PY - 2019/8/15

Y1 - 2019/8/15

N2 - Background: Food-related quality of life (FRQoL) evaluates the impact of diet, eating behaviors, and food-related anxiety on a person’s quality of life. This is the first study to evaluate FRQoL in inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), two illnesses where food and diet are of importance. Methods: One hundred seventy-five participants (80 IBS, 95 IBD) participated in the study by completing measures evaluating FRQoL, psychological distress, and health-related quality of life. Primary analyses evaluated differences in FRQoL between IBD and IBS patients. Secondary analyses compared differences based on remission status, dietary use, and dietary consultation, as well as evaluated potential predictors of FRQoL. Results: IBD patients in remission report the highest FRQoL (IBD-remission: 91.2 (26.5) vs. IBD-active: 67.7 (19.6) and IBS-active: 67.6 (18.3), p <.001). Using more dietary treatments is associated with decreased FRQoL for IBS (r = − 0.23, p <.05) and IBD patients (r = − 0.31, p <.01). IBS patients are more likely to use dietary treatments than IBD (IBS = 81% vs. IBD = 64%, p <.01), with self-directed diets being the most commonly used approach. Symptom severity is the strongest predictor of FRQoL in both groups (IBD: R2 =.27, p <.01; IBS: R2 =.23, p <.001). Conclusion: FRQoL is a unique construct for IBD and IBS patients that can be influenced by several clinical and dietary factors, including number of diets and type of diet used, depending on the diagnosis. Thus, FRQoL should be considered when working with both IBD and IBS patients.

AB - Background: Food-related quality of life (FRQoL) evaluates the impact of diet, eating behaviors, and food-related anxiety on a person’s quality of life. This is the first study to evaluate FRQoL in inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), two illnesses where food and diet are of importance. Methods: One hundred seventy-five participants (80 IBS, 95 IBD) participated in the study by completing measures evaluating FRQoL, psychological distress, and health-related quality of life. Primary analyses evaluated differences in FRQoL between IBD and IBS patients. Secondary analyses compared differences based on remission status, dietary use, and dietary consultation, as well as evaluated potential predictors of FRQoL. Results: IBD patients in remission report the highest FRQoL (IBD-remission: 91.2 (26.5) vs. IBD-active: 67.7 (19.6) and IBS-active: 67.6 (18.3), p <.001). Using more dietary treatments is associated with decreased FRQoL for IBS (r = − 0.23, p <.05) and IBD patients (r = − 0.31, p <.01). IBS patients are more likely to use dietary treatments than IBD (IBS = 81% vs. IBD = 64%, p <.01), with self-directed diets being the most commonly used approach. Symptom severity is the strongest predictor of FRQoL in both groups (IBD: R2 =.27, p <.01; IBS: R2 =.23, p <.001). Conclusion: FRQoL is a unique construct for IBD and IBS patients that can be influenced by several clinical and dietary factors, including number of diets and type of diet used, depending on the diagnosis. Thus, FRQoL should be considered when working with both IBD and IBS patients.

KW - Diet

KW - Inflammatory bowel disease

KW - Irritable bowel syndrome

KW - Outcomes research

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=85063280377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063280377&partnerID=8YFLogxK

U2 - 10.1007/s11136-019-02170-4

DO - 10.1007/s11136-019-02170-4

M3 - Article

C2 - 30900206

AN - SCOPUS:85063280377

VL - 28

SP - 2195

EP - 2205

JO - Quality of Life Research

JF - Quality of Life Research

SN - 0962-9343

IS - 8

ER -